Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study.

Yunxiang ZhouXianan GuoLu ShenKexin LiuQunan SunYali WangHui WangWenyu FuYihan YaoShijie WuHuihui ChenJili QiuTao PanYongchuan Deng

Published in: OncoTargets and therapy (2023)

As a predictor of breast cancer, especially in the HR-positive subtype, SII may eclipse NLR/PLR. SII-high patients are more likely to have a worse chemotherapy response and a higher risk of recurrence.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
oxidative stress
squamous cell carcinoma
patient reported outcomes
locally advanced
young adults
patient reported
childhood cancer